Lead Product(s): Human gut microbiome
Therapeutic Area: Nephrology Product Name: Undisclosed
Highest Development Status: IND Enabling Product Type: Large molecule
Partner/Sponsor/Collaborator: Horizons Ventures
Deal Size: $50.0 million Upfront Cash: Undisclosed
Deal Type: Series A Financing October 06, 2020
Federation Bio will use proceeds from the financing to build out its in-house development process to enable Phase 1/2 manufacturing and advance its lead program into the clinic.